Patrick J. Hanley

3.6k total citations
119 papers, 2.3k citations indexed

About

Patrick J. Hanley is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Patrick J. Hanley has authored 119 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 49 papers in Epidemiology and 44 papers in Immunology. Recurrent topics in Patrick J. Hanley's work include CAR-T cell therapy research (46 papers), Cytomegalovirus and herpesvirus research (45 papers) and Immune Cell Function and Interaction (28 papers). Patrick J. Hanley is often cited by papers focused on CAR-T cell therapy research (46 papers), Cytomegalovirus and herpesvirus research (45 papers) and Immune Cell Function and Interaction (28 papers). Patrick J. Hanley collaborates with scholars based in United States, United Kingdom and Canada. Patrick J. Hanley's co-authors include Catherine M. Bollard, Carolina Colli Cruz, Cliona M. Rooney, Helen E. Heslop, Adrian P. Gee, Elizabeth J. Shpall, Hao Liu, Ann M. Leen, Malcolm K. Brenner and Michael D. Keller and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Patrick J. Hanley

112 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick J. Hanley United States	27	1.2k	842	816	524	362	119	2.3k
Caridad Martinez United States	16	1.7k 1.5×	568 0.7×	926 1.1×	870 1.7×	748 2.1×	54	2.8k
Kathryn Leung United States	16	1.0k 0.9×	839 1.0×	727 0.9×	627 1.2×	290 0.8×	50	2.1k
Michele Fimiani Italy	29	836 0.7×	630 0.7×	447 0.5×	246 0.5×	366 1.0×	177	2.7k
Matthias Eyrich Germany	27	556 0.5×	446 0.5×	752 0.9×	263 0.5×	233 0.6×	93	1.8k
Brigitte Sénéchal United States	18	2.3k 1.9×	436 0.5×	1.6k 2.0×	631 1.2×	813 2.2×	43	4.0k
Yukio Sakiyama Japan	26	486 0.4×	319 0.4×	905 1.1×	489 0.9×	495 1.4×	118	2.4k
Venetia Bigley United Kingdom	21	631 0.5×	314 0.4×	2.2k 2.7×	178 0.3×	677 1.9×	39	3.2k
Paul Szabolcs United States	29	1.1k 0.9×	919 1.1×	2.5k 3.1×	486 0.9×	577 1.6×	111	4.8k
Christian S. Kuhr United States	25	431 0.4×	393 0.5×	304 0.4×	474 0.9×	623 1.7×	63	2.1k
Linda Wooldridge United Kingdom	31	899 0.8×	537 0.6×	2.3k 2.8×	233 0.4×	568 1.6×	66	3.8k

Countries citing papers authored by Patrick J. Hanley

Since Specialization

Citations

This map shows the geographic impact of Patrick J. Hanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Hanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Hanley more than expected).

Fields of papers citing papers by Patrick J. Hanley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. Hanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Hanley. The network helps show where Patrick J. Hanley may publish in the future.

Co-authorship network of co-authors of Patrick J. Hanley

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick J. Hanley. A scholar is included among the top collaborators of Patrick J. Hanley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick J. Hanley. Patrick J. Hanley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keller, Michael D., Stefan Schattgen, Shanmuganathan Chandrakasan, et al.. (2024). Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication. Nature Communications. 15(1). 2749–2749. 3 indexed citations

Wistinghausen, Birte, Donald A. Barkauskas, Lauren Saguilig, et al.. (2024). Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study. Blood Advances. 8(5). 1116–1127. 6 indexed citations

Webb, Jennifer, et al.. (2024). Environmental monitoring of current good manufacturing practices cleanroom facilities for manufacturing of cellular therapy products in an academic hospital setting. Cytotherapy. 26(11). 1421–1428. 2 indexed citations

Grimley, Michael, Tom Leemhuis, José A. Cancelas, et al.. (2024). Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. American Journal of Transplantation. 24(9). 1634–1643. 13 indexed citations

Motlagh, Delara, et al.. (2022). Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies. Cell and Gene Therapy Insights. 8(7). 1083–1095. 1 indexed citations

Rubinstein, Jeremy D., Carolyn Lutzko, Tom Leemhuis, et al.. (2021). Scheduled Donor-Derived Viral Specific T-Cells for Prophylaxis Against Double Stranded DNA Viral Infection after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(3). S87–S88. 1 indexed citations

Rubinstein, Jeremy D., Sonata Jodele, Jamie Wilhelm, et al.. (2021). Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 28(2). 116.e1–116.e7. 17 indexed citations

Lazarski, Christopher A., et al.. (2020). Identification of new cytokine combinations for antigen-specific T-cell therapy products via a high-throughput multi-parameter assay. Cytotherapy. 23(1). 65–76. 9 indexed citations

Abraham, Allistair, Michael D. Keller, Carolina Colli Cruz, et al.. (2019). Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Advances. 3(14). 2057–2068. 33 indexed citations

10.

Maeda, Takuya, et al.. (2019). Impact of Mesenchymal Stromal Cell Delivery Through Cardiopulmonary Bypass on Postnatal Neurogenesis. The Annals of Thoracic Surgery. 109(4). 1274–1281. 10 indexed citations

11.

Dave, Hema, et al.. (2019). Driving the CAR to the Bone Marrow Transplant Program. Current Hematologic Malignancy Reports. 14(6). 561–569. 10 indexed citations

12.

Hanley, Patrick J., Michael D. Keller, Haili Lang, et al.. (2017). Clinical Use of CMV-Specific T Cells Derived from CMV-Naïve Donors. Blood. 130. 4470–4470. 1 indexed citations

13.

Simpson, Richard J., Austin B. Bigley, Nadia H. Agha, Patrick J. Hanley, & Catherine M. Bollard. (2017). Mobilizing Immune Cells With Exercise for Cancer Immunotherapy. Exercise and Sport Sciences Reviews. 45(3). 163–172. 40 indexed citations

14.

McLaughlin, Lauren P., Haili Lang, Elizabeth D. Williams, et al.. (2016). Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes. Cytotherapy. 18(12). 1515–1524. 27 indexed citations

15.

Hanley, Patrick J., Zhuyong Mei, April Durett, et al.. (2014). Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System. Cytotherapy. 16(8). 1048–1058. 121 indexed citations

16.

Bear, Adham S., Patrick J. Hanley, Doyle Bosque, et al.. (2014). Low rate of infusional toxicity after expanded cord blood transplantation. Cytotherapy. 16(8). 1153–1157. 6 indexed citations

17.

Hanley, Patrick J., Zhuyong Mei, Maria da Graça Cabreira-Hansen, et al.. (2013). Manufacturing mesenchymal stromal cells for phase I clinical trials. Cytotherapy. 15(4). 416–422. 45 indexed citations

18.

Hanley, Patrick J., Sharon Lam, Elizabeth J. Shpall, & Catherine M. Bollard. (2012). Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus. Journal of Visualized Experiments. e3627–e3627. 21 indexed citations

19.

Lambert, Lauren A., Lorena Espinoza, Maryam B. Haddad, et al.. (2007). Transmission of Mycobacterium tuberculosis in a Tennessee Prison, 2002-2004. Journal of Correctional Health Care. 14(1). 39–47. 10 indexed citations

20.

Hanley, Patrick J., et al.. (1993). Nosocomial herpes simplex virus infection associated with oral endotracheal intubation. American Journal of Infection Control. 21(6). 310–316. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact